Medical Treatments

(asked on 5th July 2021) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what progress his Department has made on research on the efficacy of (a) monoclonal antibodies and (b) other alternative treatments for immunocompromised and immunosuppressed groups.


Answered by
Edward Argar Portrait
Edward Argar
Minister of State (Ministry of Justice)
This question was answered on 13th July 2021

The National Institute for Health Research (NIHR) has supported 15 studies on monoclonal antibodies and other therapies for immunocompromised and immunosuppressed groups, including cell therapy and the use of probiotics. Twelve of these studies are now complete and three are ongoing. All NIHR-funded research is expected to be published in peer-reviewed, open access journals once completed to promote translation into patient care where appropriate.

Reticulating Splines